AUTOLUS THERAPEUTICS P
3.3250
27-November-24 11:57:59
15 minutes delayed
Stocks
+0.2300
+7.43%
Today's range
3.1300 - 3.3900
ISIN
N/A
Source
NASDAQ
-
Autolus Therapeutics announces publication in Blood Cancer Journal
11 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
29 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics announces publication in Nature Communications
22 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
Autolus Announces Pricing of Underwritten Offering
08 Feb 2024 07:00:46 By Nasdaq GlobeNewswire
-
08 Feb 2024 05:45:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics announces publication in ACS Chemical Biology
23 Jan 2024 07:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics announces the appointment of Robert W. Azelby to its Board of Directors
10 Jan 2024 07:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Announces Changes to its Board of Directors
22 Dec 2023 07:00:00 By Nasdaq GlobeNewswire
-
09 Dec 2023 20:30:00 By Nasdaq GlobeNewswire
-
15 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics announces participation in upcoming conferences
06 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
02 Nov 2023 09:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Reports Third Quarter 2023 Financial Results and Business Updates
02 Nov 2023 07:11:50 By Nasdaq GlobeNewswire
-
17 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
11 Oct 2023 08:07:12 By Nasdaq GlobeNewswire
-
11 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Reports Second Quarter 2023 Financial Results and Operational Progress
03 Aug 2023 07:00:01 By Nasdaq GlobeNewswire
-
Autolus Therapeutics announces appointment of Robert F. Dolski as Chief Financial Officer
19 Jul 2023 07:00:00 By Nasdaq GlobeNewswire